Clinical Trials
6 trialsNCT03177187 2024-09-26
ACE
Institute of Cancer Research, United Kingdom
Phase 1/2 Terminated
NCT04458311 2024-04-25
ACTIon
Institute of Cancer Research, United Kingdom
Phase 1/2 Terminated
NCT05124795 2024-01-17
IMU-935 in Patients With Progressive, Metastatic Castration Resistant Prostate Cancer
Immunic AG
Phase 1 Terminated
NCT03752099 2023-09-26
To Evaluate Safety and Tolerability of VERU-111 in Men With Advanced Metastatic Castration Resistant Prostate Cancer
Veru Inc.
Phase 1/2 Terminated
NCT04634344 2022-07-11
Assess the Safety, Tolerability, PK and Anti-tumor Efficacy of DZD2269 in Patients With MCRPC
Dizal Pharmaceuticals
Phase 1 Terminated
NCT03042312 2021-03-24
RESIST-PC
Endocyte
Phase 2 Terminated